An observational study in Intracranial Hemorrhages, sponsored by Heuron Inc.. Completed at 1 site in Korea, Republic of. Open to participants aged 19 Years and older. Per ClinicalTrials.gov, last updated 2022-01-14.
Sponsored by Heuron Inc. · Observational
cHS is a software that has been pre-learned based on a intracranial haemorrhage diagnosis model using brain CT images, and clinical decision support system for diagnosing intracranial haemorrhage by automatically analyzing brain CT images by assisting the medical team.
The specific aims of this study are to evaluate efficacy of cHS for intracranial haemorrhage compared to the sensitivity and specificity levels of predicate device which is currently approved to triage intracranial haemorrhage.
199 studies on the registry are indexed under Intracranial Hemorrhages; 64 are open to participants now.
This study's enrollment of 236 is close to the median of 240 across 87 observational studies indexed under Intracranial Hemorrhages.
Browse Intracranial Hemorrhages studies →Heuron Inc. is the lead sponsor of 7 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
(1) Adults over 19 years old (2) Brain CT images acquired (3) who confirmed with intracranial haemorrhage(abnormal cohort) or not intracranial haemorrhage or normal(normal cohort)
Exclusion Criteria:
A patient diagnosed with intracranial haemorrhage after a brain CT scan
Device: cHS
A normal person or a patient not diagnosed with intracranial haemorrhage after a brain CT scan
Device: cHS
Clinical decision support system for diagnosing intracranial haemorrhage
Sensitivity and specificity of cHS
Sensitivity and specificity of cHS in diagnosis of intracranial haemorrhage based on golden standards
Time frame: Within 4 weeks after collecting data
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Jan 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Heuron Inc.